Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 485

1.

Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.

Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME.

Drugs. 2008;68(13):1841-54.

PMID:
18729535
2.

Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials.

Kyriakidou KG, Rafailidis P, Matthaiou DK, Athanasiou S, Falagas ME.

Clin Ther. 2008 Oct;30(10):1859-68. doi: 10.1016/j.clinthera.2008.10.007.

PMID:
19014841
5.

Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children.

Karageorgopoulos DE, Valkimadi PE, Kapaskelis A, Rafailidis PI, Falagas ME.

Arch Dis Child. 2009 Aug;94(8):607-14. doi: 10.1136/adc.2008.151563. Review.

PMID:
19628879
6.

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

File TM Jr, Mandell LA, Tillotson G, Kostov K, Georgiev O.

J Antimicrob Chemother. 2007 Jul;60(1):112-20.

8.

Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.

Athanassa Z, Makris G, Dimopoulos G, Falagas ME.

Drugs. 2008;68(17):2469-81. doi: 10.2165/0003495-200868170-00005.

PMID:
19016574
9.

Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.

Li JZ, Winston LG, Moore DH, Bent S.

Am J Med. 2007 Sep;120(9):783-90.

PMID:
17765048
11.

Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials.

Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK.

Br J Clin Pharmacol. 2009 Feb;67(2):161-71. doi: 10.1111/j.1365-2125.2008.03306.x.

12.

Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.

Haider BA, Saeed MA, Bhutta ZA.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005976. doi: 10.1002/14651858.CD005976.pub2. Review.

PMID:
18425930
13.

Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.

Bradley JS, Arguedas A, Blumer JL, Sáez-Llorens X, Melkote R, Noel GJ.

Pediatr Infect Dis J. 2007 Oct;26(10):868-78.

PMID:
17901791
14.

Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.

Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA.

Pediatr Pulmonol. 2003 Feb;35(2):91-8.

PMID:
12526069
15.
16.

A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.

Vetter N, Cambronero-Hernandez E, Rohlf J, Simon S, Carides A, Oliveria T, Isaacs R; Protocol 020 Study Group..

Clin Ther. 2002 Nov;24(11):1770-85.

PMID:
12501873
17.

Meta-analysis: ertapenem for complicated intra-abdominal infections.

Falagas ME, Peppas G, Makris GC, Karageorgopoulos DE, Matthaiou DK.

Aliment Pharmacol Ther. 2008 May;27(10):919-31. doi: 10.1111/j.1365-2036.2008.03642.x.

18.

Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.

Ortiz-Ruiz G, Vetter N, Isaacs R, Carides A, Woods GL, Friedland I.

J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii59-66.

19.

Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia.

Bradley JS, McCracken GH.

Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S241-8. doi: 10.1086/591410. Review.

20.
Items per page

Supplemental Content

Support Center